Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-31 @ 3:14 PM
Study NCT ID:
NCT00565058
Status:
COMPLETED
Last Update Posted:
2015-07-27
First Post:
2007-11-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
Sponsor:
Aptose Biosciences Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia | View |
Keywords: